NFE2L2 and pulmonary fibrosis: It has been reported that the deletion of Nrf2 in mice leads to decreased expression levels of antioxidant enzymes and phase II detoxifying enzymes, resulting in more severe bleomycin-induced inflammation and pulmonary fibrosis [170].